|
Cecilia Davoli is the Director of Environmental and International Health at Kennedy Krieger Institute. She is also an Assistant Professor in Pediatrics at Johns Hopkins University School of Medicine, and an Assistant Professor of Environmental Health Sciences at Johns Hopkins University School of Hygiene and Public Health.
Biographical Sketch:
Dr. Davoli graduated in 1980 from The College of William and Mary with a B.S. in Biology. She continued her education at Georgetown University School of Medicine where she received an M.D. in 1987. Following her graduation, she did a Residency in Pediatrics at University of Virginia Medical Center from 1987-1990 and a Fellowship in Developmental Pediatrics at Kennedy Krieger Institute from 1990-1993. Dr. Davoli received her masters in Public Health from Johns Hopkins University School of Hygiene and Public Health in May 2002. She has worked at Kennedy Krieger Institute since 1990 as a Developmental Pediatrician, the Medical Director of the Community Lead Poisoning Prevention and Treatment Center, and now the Director of the Environmental Health Clinic and The International Adoption Clinic. She also coordinates the Global Consultation Service at Kennedy Krieger Institute, and assists with the medical record review and subspecialty evaluation of international patients.
Dr. Davoli is a Fellow of the American Academy of Pediatrics, as well as a member of the Kennedy Fellows Association, Society for Developmental Pediatrics and the American Academy of Cerebral Palsy and Developmental Medicine. She is also currently serving an appointment to the Governor's Children's Environmental Health and Protection Advisory Council for the State of Maryland.
Research Summary:
Dr. Davoli is board certified in Pediatrics and in Neurodevelopmental Disabilities. She works with a multidisciplinary team of professionals to coordinate the evaluation and treatment of children with environmental health concerns. She is currently co-investigator in a multicenter clinical trial assessing the developmental outcome of children with moderately elevated blood lead levels who were treated with oral chelation and remedial environmental measures. Her efforts to prevent childhood lead poisoning involve her in educational outreach through the Baltimore City Public Schools and through the city and state government. She has collaborated with colleagues at the Johns Hopkins University School of Hygiene and Public Health on other projects aimed at prevention of childhood exposure to environmental toxicants.
Recent Publications/Presentations:
Davoli CT, Warren LR. Community lead poisoning prevention and treatment program model. Princeton, New Jersey: Center for Health Care Strategies, Inc. 1999.
Sithisanrankul P, Weaver V, Davoli CT, Strickland P. Urinary 5-Aminolevulinic Acid in Lead-Exposed Children. Biomarkers. 1999;4:281-289.
Treatment of Lead-Exposed Children (TLC) Trial Group. Safety and Efficacy of Succimer in Toddlers with Blood Lead Levels of 20-44 ƒÝg/dL. Pediatric Research. 2000; 48:593-599.
Treatment of Lead-Exposed Children (TLC) Trial Group. The Effect of Chelation Therapy with Succimer on Neuropsychological Development in Children Exposed to Lead. NEJM. 2001;344(19):1421-1426.
Davoli CT, Goldstein GW. Childhood Lead Poisoning. Current Therapy in Neurologic Disease. Mosby, Inc; 2002: 353-375. | 